$SPRY news

The latest SPRY stock news: headlines, filings, AI summaries and sentiment for $SPRY, updated around the clock.

• ARS Pharmaceuticals Reports Q3 2026 Revenue Growth Driven by neffy Nasal Spray Adoption Motley Fool · November 6, 2026, 14:08 UTC
• ARS Pharmaceuticals Targets Cash Flow Breakeven by Year-End 2027 Seeking Alpha · November 6, 2026, 13:25 UTC
• ARS Pharmaceuticals, Inc. - 10-Q Filing SEC EDGAR · November 5, 2026, 21:07 UTC
• ARS Pharmaceuticals, Inc. - 8-K Filing SEC EDGAR · November 5, 2026, 21:04 UTC
• Class Action Lawsuit Filed Against ARS Pharmaceuticals Over Insurance Coverage for Neffy PR Newswire · September 24, 2026, 20:15 UTC
• Class Action Lawsuit Filed Against ARS Pharmaceuticals Over Insurance Coverage for Neffy PR Newswire · September 10, 2026, 14:00 UTC
• ARS Pharmaceuticals, Inc. - 8-K Filing SEC EDGAR · July 17, 2026, 20:02 UTC
• ARS Pharmaceuticals Appoints Donn Casale As New CEO Yahoo Finance · July 15, 2026, 15:42 UTC
• Investor Alert: Pomerantz Law Firm Investigates ARS Pharmaceuticals for Potential Securities Fraud PR Newswire · July 9, 2026, 21:35 UTC
• ARS Pharmaceuticals Appoints New CEO Seeking Alpha · July 7, 2026, 20:35 UTC
• ARS Pharmaceuticals, Inc. - 8-K Filing SEC EDGAR · July 7, 2026, 20:39 UTC
• ARS Pharmaceuticals, Inc. - 8-K Filing SEC EDGAR · June 26, 2026, 06:29 UTC
• ARS Pharma Reports Q1 2026 Earnings Motley Fool · May 18, 2026, 13:07 UTC
• ARS Pharma Reports Q1 2026 Earnings Yahoo Finance · May 18, 2026, 13:27 UTC
• Ars Pharmaceuticals Expands $199 Retail Access Program Amid Anticipation for CVS Caremark Decision Seeking Alpha · May 16, 2026, 01:32 UTC
• ARS Pharma Reports Q4 2025 Earnings with $72.2 Million Net Product Revenue Motley Fool · May 15, 2026, 21:38 UTC